Low incidence of follicular lymphoma and t(14;18)(q32;q21) by polymerase chain reaction analysis. observations on Ecuadorian patients.

Cancer Genet Cytogenet

Laboratorio de Genética Molecular y Citogenética Humana, Departamento de Ciencias Biológicas, Pontificia Universidad Católica del Ecuador, Quito, Ecuador.

Published: August 2002

Translocation (14;18)(q32;q21) has been shown to be present in diagnostic tissue specimens from approximately 85% of patients with follicular lymphoma (FL) and 30% with diffuse non-Hodgkin lymphomas (NHL) in the USA. Also, there is evidence that the distribution of NHL subtypes differs by geographic region; however, there are no data for Ecuador. Using polymerase chain reaction, we examined the frequency of t(14;18) (MBR and mcr rearrangements) in 65 NHL samples collected through 5 years from the principal hospitals of Quito, Ecuador. Of 65 NHL, only 5 were FL, which represents an incidence of 7.7%. This incidence is lower than observed in North America (30%). In addition, we did not find the t(14;18) in the samples analyzed, absence of which was confirmed by the use of a control. This suggests that this translocation is rare in NHL in Ecuador. These findings confirm that there are differences in the incidence of specific subtypes of NHL across some geographic areas and suggest that genetic factors may be responsible for the observed differences.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-4608(02)00542-3DOI Listing

Publication Analysis

Top Keywords

follicular lymphoma
8
polymerase chain
8
chain reaction
8
nhl
6
low incidence
4
incidence follicular
4
lymphoma t1418q32q21
4
t1418q32q21 polymerase
4
reaction analysis
4
analysis observations
4

Similar Publications

T cell lymphoma constitutes a complex group of diseases, characterized by heterogeneous molecular features and clinical symptoms, and a dismal outcome no matter the therapeutic strategy chosen. In an attempt to improve patients' survival chances, treatment combinations (chemotherapy, radiotherapy, immunotherapy, gene therapy and thermotherapy) have been tested for their synergistic effects that may dramatically improve outcomes and reduce the side effects of each single modality treatment when therapeutic effects add up while side effects are distributed. In this context, nanoscale drug delivery agents have been developed and exploited to enhance the release of drugs in the treatment of several diseases, showing potential benefits in terms of pharmaceutical flexibility, selectivity, dose reduction and minimization of adverse effects.

View Article and Find Full Text PDF

Testicular follicular lymphoma (TFL) is an exceedingly rare lymphoma that typically occurs in young male patients and is now recognized as a distinct diagnostic entity in the International Consensus Classification. TFL shows some clinicopathologic and genetic overlap with pediatric-type follicular lymphoma (PTFL). We report a case of TFL occurring in an otherwise healthy 4-year-old boy who presented with painless scrotal swelling.

View Article and Find Full Text PDF

The Role of Small Bowel Capsule Endoscopy in Determining the Treatment Strategy for Duodenal Follicular Lymphoma: A Single-Center Retrospective Study.

Diagnostics (Basel)

January 2025

Department of Hematology, Catholic University Lymphoma Group, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Banpo-daero 222, Seocho-Gu, Seoul 06591, Republic of Korea.

: In this single-center retrospective study, we aimed to verify the extent of duodenal follicular lymphoma (DFL) and investigate the role and clinical significance of video capsule endoscopy (VCE) in the treatment process. : We analyzed the clinical and imaging data of 40 patients diagnosed with DFL. : Imaging workup and bone marrow biopsies revealed DFL only in the gastrointestinal tract (stage I) in 22 patients and in local lymph nodes (stage II), distant lymph nodes (stage II), pancreas (stage IIE), and extranodal regions (stage IV) in 1, 3, 1, and 13 patients, respectively.

View Article and Find Full Text PDF

Comprehensive genetic analysis of tumors with exome or whole genome sequencing has enabled the identification of the genes that are recurrently mutated in cancer. This has stimulated a series of exciting advances over the past 15 years, guiding us to new molecular biomarkers and therapeutic targets among the common mature B-cell neoplasms. In particular, diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL) and Burkitt lymphoma (BL) have each been the subject of considerable attention in this field.

View Article and Find Full Text PDF

Follicular lymphoma (FL) outcomes are heavily influenced by host immune activity with immune anti-tumor activity mitigated by PD-1/PD-L1 pathway engagement. Combination CD20-directed therapy plus PD-1 inhibition (PD-1i) increases T-cell tumor killing and NK-cell antibody-dependent cell cytotoxicity (ADCC). Mounting evidence supports immune-priming using PD-1i before cancer-directed agents.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!